| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00432-015-2020-4 |
| P698 | PubMed publication ID | 26206483 |
| P2093 | author name string | Wei Jiang | |
| Xunbo Jin | |||
| Xiaopeng Lan | |||
| Yougen Chen | |||
| Qinghua Xia | |||
| Guoliang Lu | |||
| Shaowei Mao | |||
| Chuanwei Yuan | |||
| P2860 | cites work | Trichostatin A induces mesenchymal-like morphological change and gene expression but inhibits migration and colony formation in human cancer cells | Q38951837 |
| Acetylation regulates the stability of glutamate carboxypeptidase II protein in human astrocytes | Q38983633 | ||
| Role of SMAD4 in the mechanism of valproic acid's inhibitory effect on prostate cancer cell invasiveness | Q39058636 | ||
| MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. | Q39324702 | ||
| Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion | Q39369865 | ||
| Sodium valproate inhibits MDA-MB-231 breast cancer cell migration by upregulating NM23H1 expression | Q39404011 | ||
| HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT. | Q39527047 | ||
| MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo | Q39637308 | ||
| Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo | Q39860046 | ||
| Elevated FOSB-expression; a potential marker of valproate sensitivity in AML. | Q39911930 | ||
| Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells | Q40590583 | ||
| Chromatin-modifying agents reactivate embryonic renal stem/progenitor genes in human adult kidney epithelial cells but abrogate dedifferentiation and stemness | Q41826504 | ||
| Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II. | Q45912062 | ||
| Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells | Q47589926 | ||
| Neuroprotective effects of valproic acid against hemin toxicity: possible involvement of the down-regulation of heme oxygenase-1 by regulating ubiquitin-proteasomal pathway | Q48220909 | ||
| TIF1γ requires sumoylation to exert its repressive activity on TGFβ signaling. | Q50889873 | ||
| Effects of valproic acid on proliferation, apoptosis, angiogenesis and metastasis of ovarian cancer in vitro and in vivo | Q85272127 | ||
| Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer | Q21132487 | ||
| Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells | Q24303962 | ||
| FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination | Q24315150 | ||
| Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder | Q24626017 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Regulation of TGF-β signal transduction by mono- and deubiquitylation of Smads | Q26827667 | ||
| Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination | Q26830449 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| AACR centennial series: the biology of cancer metastasis: historical perspective | Q33683443 | ||
| Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells | Q33694557 | ||
| New perspectives of valproic acid in clinical practice. | Q34380256 | ||
| Axl as a mediator of cellular growth and survival | Q34619118 | ||
| New and emerging therapies for bone metastases in genitourinary cancers | Q36866291 | ||
| Epithelial-mesenchymal transition in breast cancer progression and metastasis | Q36986452 | ||
| SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression | Q37120753 | ||
| Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer | Q37683681 | ||
| Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes | Q37762393 | ||
| Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation | Q37917310 | ||
| TGF-β signalling and its role in cancer progression and metastasis | Q38020111 | ||
| New insights into extracellular and post-translational regulation of TGF-β family signalling pathways | Q38108683 | ||
| Histone deacetylase inhibitors: an overview of the clinical studies in solid tumors | Q38159410 | ||
| Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders | Q38240733 | ||
| Breast cancer stem cells, EMT and therapeutic targets | Q38254848 | ||
| Cytoskeleton targeting value in prostate cancer treatment | Q38265569 | ||
| Histone deacetylases as therapeutic targets--from cancer to cardiac disease | Q38274751 | ||
| Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. | Q38315365 | ||
| P433 | issue | 1 | |
| P921 | main subject | prostate carcinoma | Q18553829 |
| P304 | page(s) | 177-185 | |
| P577 | publication date | 2015-07-24 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. | |
| P478 | volume | 142 |
| Q41593141 | A combination of valproic acid sodium salt, CHIR99021, E-616452, tranylcypromine, and 3-Deazaneplanocin A causes stem cell-like characteristics in cancer cells |
| Q47387460 | Combination of sorafenib and Valproic acid synergistically induces cell apoptosis and inhibits hepatocellular carcinoma growth via down-regulating Notch3 and pAkt |
| Q28071912 | Epigenetic modulators as therapeutic targets in prostate cancer |
| Q52674354 | Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control. |
| Q64243953 | Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells |
| Q36508613 | MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells |
| Q39329818 | The EMT spectrum and therapeutic opportunities |
| Q50911264 | USP17 is upregulated in osteosarcoma and promotes cell proliferation, metastasis, and epithelial-mesenchymal transition through stabilizing SMAD4. |
| Q52718768 | Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal. |
Search more.